Clinical Trial: Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase II/III

Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Study Type: INTERVENTIONAL




Official Title: Role of Umbilical Cord-derived Stem Cell Transplantation and Conditioned Medium to Inhibit Vision Loss in Retinitis Pigmentosa Phase II/III

Brief Summary: The study will perform UC-MSCs and CM transplantation.
There are two groups with different dosages.
The first group will be transplanted with 1.5 million cells, meanwhile, the second group is 5 million cells.
Each group consists of 15 subjects.
All groups will be transplanted via the peribulbar route.
All groups will be observed until six months.